Citations (14)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (6)
Miguel Turégano-Yedro, Eva Trillo-Calvo, Fernando Navarro i Ros, José David Maya-Viejo, Cruz González Villaescusa, Jose Maria Echave Sustaeta, Esperanza Doña & Bernardino Alcázar Navarrete. (2023) Inhaler Adherence in COPD: A Crucial Step Towards the Correct Treatment. International Journal of Chronic Obstructive Pulmonary Disease 18, pages 2887-2893.
Read now
Read now
Alberto Braghiroli, Fulvio Braido, Alessio Piraino, Paola Rogliani, Pierachille Santus & Nicola Scichilone. (2020) Day and Night Control of COPD and Role of Pharmacotherapy: A Review. International Journal of Chronic Obstructive Pulmonary Disease 15, pages 1269-1285.
Read now
Read now
José Luis López-Campos, Esther Quintana Gallego & Laura Carrasco Hernández. (2019) Status of and strategies for improving adherence to COPD treatment. International Journal of Chronic Obstructive Pulmonary Disease 14, pages 1503-1515.
Read now
Read now
Edward Kerwin & Gary T. Ferguson. (2018) An overview of glycopyrrolate/eFlow® CS in COPD. Expert Review of Respiratory Medicine 12:6, pages 447-459.
Read now
Read now
Mònica Monteagudo, Montse Roset, Teresa Rodriguez-Blanco, Laura Muñoz & Marc Miravitlles. (2017) Characteristics of COPD patients initiating treatment with aclidinium or tiotropium in primary care in Catalonia: a population-based study. International Journal of Chronic Obstructive Pulmonary Disease 12, pages 1145-1152.
Read now
Read now
Nicola A Hanania, Suzanne C. Lareau & Barbara P. Yawn. (2017) Safety of inhaled long-acting anti-muscarinic agents in COPD. Postgraduate Medicine 129:5, pages 500-512.
Read now
Read now
Articles from other publishers (8)
Sandra Anderson, Paul Atkins, Per Bäckman, David Cipolla, Andrew Clark, Evangelia Daviskas, Bernd Disse, Plamena Entcheva-Dimitrov, Rick Fuller, Igor Gonda, Hans Lundbäck, Bo Olsson & Jeffry Weers. (2022) Inhaled Medicines: Past, Present, and Future. Pharmacological Reviews 74:1, pages 48-118.
Crossref
Crossref
Xiuyan Lan, Xinyan Lu, Bilan Yi, Xiaohuan Chen & Shuang Jin. (2021) Factors associated with self‐management behaviors of patients with chronic obstructive pulmonary disease. Japan Journal of Nursing Science 19:1.
Crossref
Crossref
F. Dalon, E. Van Ganse, C. Correia Da Silva, G. Nachbaur, L. Saïl & M. Belhassen. (2019) Revue générale sur l’adhésion aux traitements inhalés de la BPCO. Revue des Maladies Respiratoires 36:7, pages 801-849.
Crossref
Crossref
Patrick Redmond, Ronald McDowell, Tamasine C Grimes, Fiona Boland, Ronan McDonnell, Carmel Hughes & Tom Fahey. (2019) Unintended discontinuation of medication following hospitalisation: a retrospective cohort study. BMJ Open 9:6, pages e024747.
Crossref
Crossref
Miriam Barrecheguren, Mónica Monteagudo & Marc Miravitlles. (2018) Population-based study of LAMA monotherapy effectiveness compared with LABA/LAMA as initial treatment for COPD in primary care. npj Primary Care Respiratory Medicine 28:1.
Crossref
Crossref
F. Blasi, G. W. Canonica & M. Miravitlles. (2017) Is aclidinium alone or combined with a LABA a rational choice for symptomatic COPD patients?. Respiratory Research 18:1.
Crossref
Crossref
Paola Rogliani, Josuel Ora, Ermanno Puxeddu, Maria Gabriella Matera & Mario Cazzola. (2017) Adherence to COPD treatment: Myth and reality. Respiratory Medicine 129, pages 117-123.
Crossref
Crossref
Hiroyuki Ohbayashi, Sahori Kudo & Masatake Ishikawa. (2017) Inhaler Operability and Patient Satisfaction Regarding Genuair® and Respimat® Inhalers for Chronic Obstructive Pulmonary Disease: A Randomized Crossover Study. Pulmonary Therapy 3:1, pages 173-185.
Crossref
Crossref